(Q34038564)

English

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma

scientific article published on 10 November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma (English)

1 reference

Europe PubMed Central

30 July 2017

0 references

10

object named as

M R Litzow

1 reference

Europe PubMed Central

30 July 2017

1

object named as

M A Gertz

1 reference

Europe PubMed Central

30 July 2017

3

object named as

M Q Lacy

1 reference

Europe PubMed Central

30 July 2017

Angela Dispenzieri

4

object named as

A Dispenzieri

1 reference

Europe PubMed Central

30 July 2017

Francis K Buadi

6

object named as

F K Buadi

1 reference

Europe PubMed Central

30 July 2017

7

object named as

D Dingli

1 reference

Europe PubMed Central

30 July 2017

author name string

S K Kumar

2

1 reference

Europe PubMed Central

30 July 2017

S R Hayman

5

1 reference

Europe PubMed Central

30 July 2017

D A Gastineau

8

1 reference

Europe PubMed Central

30 July 2017

J L Winters

9

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

10 November 2008

1 reference

Europe PubMed Central

30 July 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

30 July 2017

43

1 reference

Europe PubMed Central

30 July 2017

8

1 reference

Europe PubMed Central

30 July 2017

619-625

1 reference

Europe PubMed Central

30 July 2017

https://scigraph.springernature.com/pub.10.1038/bmt.2008.369

0 references

High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914501

5 July 2018

Current standards for first-line therapy of multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914501

5 July 2018

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914501

5 July 2018

Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914501

5 July 2018

High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914501

5 July 2018

Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914501

5 July 2018

Bone marrow stromal damage after chemo/radiotherapy: occurrence, consequences and possibilities of treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914501

5 July 2018

Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914501

5 July 2018

Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914501

5 July 2018

Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914501

5 July 2018

Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914501

5 July 2018

Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914501

5 July 2018

Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.369

21 January 2018

An analysis of the optimal timing of peripheral blood stem cell harvesting following priming with cyclophosphamide and G-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.369

21 January 2018

High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.369

21 January 2018

Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.369

21 January 2018

Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.369

21 January 2018

Transplantation without growth factor: engraftment kinetics after stem cell transplantation for primary systemic amyloidosis (AL).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.369

21 January 2018

Bone Marrow Stroma Damage Induced by Chemotherapy for Acute Lymphoblastic Leukemia in Children

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.369

21 January 2018

Reduced intensity conditioning compared to standard conditioning preserves the in vitro growth capacity of bone marrow stroma, which remains of host origin

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.369

21 January 2018

Hematopoietic progenitor cell large volume leukapheresis (LVL) on the Fenwal Amicus blood separator

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autografting with bone marrow exposed to multiple courses of very high dose cyclophosphamide in vivo and to 4-hydroperoxycyclophosphamide in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood cell harvests yield primitive multilineage progenitor cells in the CD34+/33- fraction

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood progenitor cell harvesting in multiple myeloma and malignant lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mobilization of peripheral blood progenitor cells with high-dose cyclophosphamide (4 or 7 g/m2) and granulocyte colony-stimulating factor in patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide Mobilization Does Not Improve Outcome in Patients Receiving Stem Cell Transplantation for Multiple Myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18997825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BMT.2008.369

1 reference

Europe PubMed Central

30 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34038564&oldid=1573466986"